Log in to save to my catalogue

Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandem...

Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandem...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7313529

Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic

About this item

Full title

Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic

Publisher

England: BMJ Publishing Group LTD

Journal title

British journal of ophthalmology, 2021-05, Vol.105 (5), p.639-647

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

BackgroundImmunomodulatory therapy (IMT) is often considered for systemic treatment of non-infectious uveitis (NIU). During the evolving coronavirus disease-2019 (COVID-19) pandemic, given the concerns related to IMT and the increased risk of infections, an urgent need for guidance on the management of IMT in patients with uveitis has emerged.Metho...

Alternative Titles

Full title

Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7313529

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7313529

Other Identifiers

ISSN

0007-1161

E-ISSN

1468-2079

DOI

10.1136/bjophthalmol-2020-316776

How to access this item